Ernexa Therapeutics (ERNA) Amortizatization of Intangibles (2019 - 2025)
Historic Amortizatization of Intangibles for Ernexa Therapeutics (ERNA) over the last 6 years, with Q3 2025 value amounting to $53000.0.
- Ernexa Therapeutics' Amortizatization of Intangibles fell 8719.81% to $53000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $191000.0, marking a year-over-year decrease of 8999.48%. This contributed to the annual value of $1.5 million for FY2024, which is 4427.33% up from last year.
- As of Q3 2025, Ernexa Therapeutics' Amortizatization of Intangibles stood at $53000.0, which was down 8719.81% from $38000.0 recorded in Q2 2025.
- In the past 5 years, Ernexa Therapeutics' Amortizatization of Intangibles ranged from a high of $534000.0 in Q2 2024 and a low of $38000.0 during Q2 2025
- Over the past 5 years, Ernexa Therapeutics' median Amortizatization of Intangibles value was $75500.0 (recorded in 2021), while the average stood at $192875.0.
- As far as peak fluctuations go, Ernexa Therapeutics' Amortizatization of Intangibles surged by 117142.86% in 2024, and later tumbled by 9288.39% in 2025.
- Ernexa Therapeutics' Amortizatization of Intangibles (Quarter) stood at $70000.0 in 2021, then decreased by 1.43% to $69000.0 in 2022, then surged by 565.22% to $459000.0 in 2023, then crashed by 89.32% to $49000.0 in 2024, then rose by 8.16% to $53000.0 in 2025.
- Its Amortizatization of Intangibles was $53000.0 in Q3 2025, compared to $38000.0 in Q2 2025 and $51000.0 in Q1 2025.